APA

Harbeck N., Kates R. E., Schmitt M., Gauger K., Kiechle M., Janicke F., Thomassen C., Look M. P. & Foekens J. A. (20050519). Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. : Clinical breast cancer.

Chicago

Harbeck Nadia, Kates Roanld E, Schmitt Manfred, Gauger Katja, Kiechle Marion, Janicke Fritz, Thomassen Christoph, Look Maxime P and Foekens John A. 20050519. Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. : Clinical breast cancer.

Harvard

Harbeck N., Kates R. E., Schmitt M., Gauger K., Kiechle M., Janicke F., Thomassen C., Look M. P. and Foekens J. A. (20050519). Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. : Clinical breast cancer.

MLA

Harbeck Nadia, Kates Roanld E, Schmitt Manfred, Gauger Katja, Kiechle Marion, Janicke Fritz, Thomassen Christoph, Look Maxime P and Foekens John A. Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. : Clinical breast cancer. 20050519.